Inferring HIV incidence from case surveillance with CD4+ cell counts.
Jansson J, Kerr CC, Mallitt KA, Wu J, Gray RT, Wilson DP
The potential impact of new generation molecular point-of-care tests on gonorrhoea and chlamydia in a setting of high endemic prevalence.
Hui BB, Wilson DP, Ward JS, Guy RJ, Kaldor JM, Law MG, Hocking JS, Regan DG
In the interests of time: improving HIV allocative efficiency modelling via optimal time-varying allocations.
Shattock AJ, Kerr CC, Stuart RM, Masaki E, Fraser N, Benedikt C, Gorgens M, Wilson DP, Gray RT
Projecting the epidemiological effect, cost-effectiveness and transmission of HIV drug resistance in Vietnam associated with viral load monitoring strategies.
Pham QD, Wilson DP, Nguyen TV, Do NT, Truong LX, Nguyen LT, Zhang L
"I Do Feel Like a Scientist at Times": A Qualitative Study of the Acceptability of Molecular Point-Of-Care Testing for Chlamydia and Gonorrhoea to Primary Care Professionals in a Remote High STI Burden Setting.
Natoli L, Guy RJ, Shephard M, Causer L, Badman SG, Hengel B, Tangey A, Ward J, Coburn T, Anderson D, Kaldor J, Maher L, TTANGO Investigators